D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 16.12 CNY -3.88% Market Closed
Market Cap: 18.3B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

DaShenLin Pharmaceutical Group Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DaShenLin Pharmaceutical Group Co Ltd
Other Operating Expenses Peer Comparison

Comparables:
603883
603939
301017
002727
A
301408

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Other Operating Expenses
ÂĄ44.8m
CAGR 3-Years
-12%
CAGR 5-Years
58%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Other Operating Expenses
ÂĄ52.6m
CAGR 3-Years
-21%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Other Operating Expenses
-ÂĄ13.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Other Operating Expenses
ÂĄ14.2m
CAGR 3-Years
643%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Other Operating Expenses
-ÂĄ91.1m
CAGR 3-Years
-8%
CAGR 5-Years
-23%
CAGR 10-Years
-11%
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Other Operating Expenses
-ÂĄ13.4m
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is DaShenLin Pharmaceutical Group Co Ltd's Other Operating Expenses?
Other Operating Expenses
44.8m CNY

Based on the financial report for Jun 30, 2024, DaShenLin Pharmaceutical Group Co Ltd's Other Operating Expenses amounts to 44.8m CNY.

What is DaShenLin Pharmaceutical Group Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
58%

Over the last year, the Other Operating Expenses growth was 1 261%. The average annual Other Operating Expenses growth rates for DaShenLin Pharmaceutical Group Co Ltd have been -12% over the past three years , 58% over the past five years .

Back to Top